A new treatment approach using an older drug may enable more patients with high-risk blood cancers to receive transplanted stem cells from unrelated, partially matched donors, according to a study conducted by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and colleagues.
Unique openings in specific ion channels could lead to development of selective drugs
Ion channels are attractive drug targets due to their importance in health and disease, but finding ways to target a specific ion channel selectively is